RWA Wealth Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,630
| Closed | -$385K | – | 539 |
|
|
2023
Q4 | $385K | Hold |
1,630
| – | – | 0.01% | 407 |
|
|
2023
Q3 | $319K | Buy |
+1,630
| New | +$319K | 0.01% | 317 |
|
|
2023
Q2 | – | Sell |
-1,422
| Closed | -$287K | – | 333 |
|
|
2023
Q1 | $287K | Hold |
1,422
| – | – | 0.01% | 213 |
|
|
2022
Q4 | $351K | Hold |
1,422
| – | – | 0.01% | 206 |
|
|
2022
Q3 | $280K | Hold |
1,422
| – | – | 0.02% | 203 |
|
|
2022
Q2 | $304K | Hold |
1,422
| – | – | 0.02% | 188 |
|
|
2022
Q1 | $404K | Sell |
1,422
-18
| -1% | -$5.11K | 0.03% | 185 |
|
|
2021
Q4 | $543K | Buy |
1,440
+18
| +1% | +$6.79K | 0.04% | 163 |
|
|
2021
Q3 | $587K | Hold |
1,422
| – | – | 0.04% | 156 |
|
|
2021
Q2 | $526K | Hold |
1,422
| – | – | 0.04% | 161 |
|
|
2021
Q1 | $412K | Hold |
1,422
| – | – | 0.03% | 175 |
|
|
2020
Q4 | $355K | Hold |
1,422
| – | – | 0.03% | 179 |
|
|
2020
Q3 | $322K | Hold |
1,422
| – | – | 0.03% | 167 |
|
|
2020
Q2 | $248K | Buy |
+1,422
| New | +$248K | 0.03% | 189 |
|
|
2020
Q1 | – | Sell |
-1,422
| Closed | -$217K | – | 206 |
|
|
2019
Q4 | $217K | Buy |
+1,422
| New | +$217K | 0.02% | 229 |
|
|
2019
Q3 | – | Sell |
-1,422
| Closed | -$202K | – | 232 |
|
|
2019
Q2 | $202K | Hold |
1,422
| – | – | 0.02% | 222 |
|
|
2019
Q1 | $207K | Buy |
+1,422
| New | +$207K | 0.02% | 219 |
|
|
2018
Q3 | – | Sell |
-1,422
| Closed | -$160K | – | 331 |
|
|
2018
Q2 | $160K | Hold |
1,422
| – | – | 0.02% | 254 |
|
|
2018
Q1 | $152K | Buy |
+1,422
| New | +$152K | 0.02% | 221 |
|